Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on PYC Therapeutics.
RELATED STOCKHEAD STORIES
Health & Biotech
August Health Winners: LTR Pharma, Control Bionics lead sector at the ‘cusp of an extraordinary era’
News
Market Highlights: US GDP boosts market confidence, and 5 ASX small caps to watch today
Health & Biotech
ASX Health Stocks: PYC to start trials for rare eye disease; OncoSil device successful in tumour removal
Health & Biotech
Broker says PYC Therapeutics’ stock price could double, or even 10x if trials succeed
Health & Biotech
ASX Health Stocks: Psilocybin drug shows promise for fibromyalgia pain relief
Health & Biotech
ASX Health Stocks: PYC’s visionary drug shows promise; Spontan ED spray available under TGA program
Health & Biotech
ASX Health Stocks: Focus on retina-disease drug study draws eyes
Health & Biotech
Beyond Resources Part 2: ASX companies driving WA’s medical and life sciences sector
Health & Biotech
ASX Health Stocks: Imricor installs key equipment at Swiss hospital
Health & Biotech
The ASX biotechs with secured FDA clearances in 2024, and others looking likely
Health & Biotech
ASX Health Stocks: FDA gives nod to PYC, and Althea’s new JV puts cannabis drinks in US bottle shops
Health & Biotech
Check Up: Introducing the Brain Atlas, the largest map of the human brain. And recent ASX biotech winners
News
Hot Money Monday: Momentum trading has been a popular strategy for decades, and here’s how you can use it
Health & Biotech
ASX Health Winners: Biotechs up 10pc in November, and Janus Henderson’s prediction for 2024
Health & Biotech
ASX Health Stocks: 4DX skyrockets 54pc after US update on its XV LVAS scanning device
Health & Biotech
ASX Health Stocks: PYC on the same page with FDA, Cleo’s cancer test peer-reviewed
News
